APLLTD Q1 FY27 results at a glance
ALEMBIC PHARMA LTD Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹2,150 cr |
|---|
| Revenue YoY | +25.7% |
|---|
| Operating profit | ₹234 cr |
|---|
| Operating margin | 10.9% |
|---|
| Net profit | ₹173 cr |
|---|
| Net profit YoY | +12.1% |
|---|
| Net profit QoQ | -14.6% |
|---|
| Net margin | 8.1% |
|---|
| Basic EPS | ₹8.80 |
|---|
| TTM revenue | ₹7,585 cr |
|---|
| TTM net profit | ₹663 cr |
|---|
| TTM net margin | 8.7% |
|---|
APLLTD Q1 FY27 results: what the numbers say
ALEMBIC PHARMA LTD (APLLTD) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹2,150 cr and a net profit of ₹173 cr, translating into earnings per share of ₹8.80.
Compared with the same quarter a year earlier, revenue grew strongly by +25.7% and net profit grew by +12.1%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹234 cr, an operating margin of 10.9% versus 12.1% a year ago — a contraction of 1.2 percentage points.
APLLTD quarter-wise results table
Revenue
₹2,150 cr
+25.7% YoY
Net profit
₹173 cr
+12.1% YoY
Operating profit
₹234 cr
+12.8% YoY
ALEMBIC PHARMA LTD (APLLTD) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹2,150 cr | ₹234 cr | ₹173 cr | 10.9% | 8.1% | ₹8.80 | +12.1% | -14.6% |
| Q4 FY262026-03-31 | ₹1,848 cr | ₹139 cr | ₹203 cr | 7.5% | 11.0% | ₹10.31 | +29.2% | +52.4% |
| Q3 FY262025-12-31 | ₹1,876 cr | ₹213 cr | ₹133 cr | 11.4% | 7.1% | ₹6.76 | — | -13.9% |
| Q1 FY262025-06-30 | ₹1,711 cr | ₹208 cr | ₹154 cr | 12.1% | 9.0% | ₹7.85 | — | -1.6% |
| Q4 FY252025-03-31 | ₹1,770 cr | ₹203 cr | ₹157 cr | 11.5% | 8.9% | ₹7.98 | — | — |
| TTM (last 4 quarters) | ₹7,585 cr | ₹794 cr | ₹663 cr | 10.5% | 8.7% | ₹33.72 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
APLLTD quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ALEMBIC PHARMA LTD quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹2,150 cr | ₹1,848 cr | ₹1,876 cr | ₹1,711 cr | ₹1,770 cr |
|---|
| Total expenses | ₹1,916 cr | ₹1,708 cr | ₹1,663 cr | ₹1,503 cr | ₹1,567 cr |
|---|
| Gross profit | ₹1,530 cr | ₹1,316 cr | ₹1,347 cr | ₹1,303 cr | ₹1,239 cr |
|---|
| Operating profit (EBIT) | ₹234 cr | ₹139 cr | ₹213 cr | ₹208 cr | ₹203 cr |
|---|
| Operating margin | 10.9% | 7.5% | 11.4% | 12.1% | 11.5% |
|---|
| Interest cost | ₹27.61 cr | ₹22.56 cr | ₹23.31 cr | ₹23.52 cr | ₹24.52 cr |
|---|
| Profit before tax | ₹222 cr | ₹119 cr | ₹162 cr | ₹190 cr | ₹192 cr |
|---|
| Tax expense | ₹49.5 cr | -₹82.91 cr | ₹29.54 cr | ₹36.48 cr | ₹35.31 cr |
|---|
| Effective tax rate | 22.3% | -69.9% | 18.3% | 19.2% | 18.4% |
|---|
| Net profit (PAT) | ₹173 cr | ₹203 cr | ₹133 cr | ₹154 cr | ₹157 cr |
|---|
| Net profit margin | 8.1% | 11.0% | 7.1% | 9.0% | 8.9% |
|---|
| Basic EPS | ₹8.80 | ₹10.31 | ₹6.76 | ₹7.85 | ₹7.98 |
|---|
| Diluted EPS | ₹8.80 | ₹10.31 | ₹6.76 | ₹7.85 | ₹7.98 |
|---|
APLLTD results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +25.7% | +4.4% | — | — | — |
|---|
| Revenue QoQ | +16.3% | -1.5% | +9.7% | -3.3% | — |
|---|
| Operating profit YoY | +12.8% | -31.3% | — | — | — |
|---|
| Operating profit QoQ | +68.1% | -34.7% | +2.8% | +2.3% | — |
|---|
| Net profit YoY | +12.1% | +29.2% | — | — | — |
|---|
| Net profit QoQ | -14.6% | +52.4% | -13.9% | -1.6% | — |
|---|
| EPS YoY | +12.1% | +29.2% | — | — | — |
|---|
| EPS QoQ | -14.6% | +52.5% | -13.9% | -1.6% | — |
|---|
APLLTD annual results history
Full-year performance for ALEMBIC PHARMA LTD, useful for reading each quarter in context.
ALEMBIC PHARMA LTD annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹7,213 cr | ₹6,540 cr | ₹6,112 cr | ₹5,500 cr |
|---|
| Total expenses | ₹6,409 cr | ₹5,805 cr | ₹5,449 cr | ₹5,056 cr |
|---|
| Gross profit | ₹4,853 cr | ₹4,403 cr | ₹4,111 cr | ₹3,477 cr |
|---|
| Operating profit (EBIT) | ₹804 cr | ₹735 cr | ₹664 cr | ₹444 cr |
|---|
| Operating margin | 11.1% | 11.2% | 10.9% | 8.1% |
|---|
| Interest cost | ₹93.63 cr | ₹78.77 cr | ₹56.19 cr | ₹50.17 cr |
|---|
| Profit before tax | ₹694 cr | ₹707 cr | ₹632 cr | ₹355 cr |
|---|
| Tax expense | ₹23.12 cr | ₹125 cr | ₹16 cr | ₹12.61 cr |
|---|
| Effective tax rate | 3.3% | 17.7% | 2.5% | 3.6% |
|---|
| Net profit (PAT) | ₹675 cr | ₹583 cr | ₹616 cr | ₹342 cr |
|---|
| Net profit margin | 9.4% | 8.9% | 10.1% | 6.2% |
|---|
| Basic EPS | ₹34.33 | ₹29.68 | ₹31.33 | ₹17.40 |
|---|
| Diluted EPS | ₹34.33 | ₹29.68 | ₹31.33 | ₹17.40 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹2,150 cr against ₹1,711 cr in Q1 FY26, and ₹1,848 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +16.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹1,916 cr, or 89.1% of revenue, with operating profit grew +12.8% year on year.
Margins, tax and profitability
Net profit of ₹173 cr works out to a net margin of 8.1% compared with 9.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, ALEMBIC PHARMA LTD reported profit before tax of ₹222 cr, a tax charge of ₹49.5 cr (effective rate 22.3%), interest cost of ₹27.61 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹203 cr in Q4 FY26 to ₹173 cr in Q1 FY27, a change of -14.6%.
Trailing twelve months and annual context
Across the trailing four quarters ALEMBIC PHARMA LTD has generated revenue of ₹7,585 cr and net profit of ₹663 cr, a trailing net margin of 8.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹7,213 cr with net profit of ₹675 cr and EPS of ₹34.33, versus the prior year where revenue grew +10.3% and profit grew +15.7%.
What to watch in the next APLLTD quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ALEMBIC PHARMA LTD has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
APLLTD results coverage
No results report published for APLLTD yet — our desk covers each quarter within minutes of the filing.
More on APLLTD
APLLTD quarterly results FAQs
What were ALEMBIC PHARMA LTD (APLLTD) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ALEMBIC PHARMA LTD reported revenue of ₹2,150 cr and net profit of ₹173 cr, a change of +12.1% year on year on +25.7% revenue growth. EPS stood at ₹8.80.
What is APLLTD profit margin in Q1 FY27?
ALEMBIC PHARMA LTD posted a net profit margin of 8.1% and an operating margin of 10.9% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹7,585 cr and net profit ₹663 cr.
Did APLLTD results beat the previous quarter?
ALEMBIC PHARMA LTD net profit changed -14.6% quarter on quarter, from ₹203 cr in Q4 FY26 to ₹173 cr in Q1 FY27.
When are ALEMBIC PHARMA LTD (APLLTD) quarterly results?
ALEMBIC PHARMA LTD has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see APLLTD latest quarterly results?
Results coverage for APLLTD will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the APLLTD stock page.
What is ALEMBIC PHARMA LTD annual revenue and profit?
For FY26, ALEMBIC PHARMA LTD reported full-year revenue of ₹7,213 cr and net profit of ₹675 cr, with EPS of ₹34.33.
How many quarterly results has APLLTD declared recently?
Past results dates for APLLTD will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
